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Abstract. 
 
Keratinocytes and other epithelial cells ex-
press two receptors for the basement membrane (BM)
extracellular matrix component laminin-5 (Ln-5), inte-
grins
 
 
 
a
 
3
 
b
 
1
 
 
 
and
 
 
 
a
 
6
 
b
 
4. While
 
 
 
a
 
3
 
b
 
1
 
 
 
mediates adhesion,
 
spreading, and migration (Kreidberg, J.A. 2000. 
 
Curr.
Opin. Cell Biol.
 
 12:548–553),
 
 
 
a
 
6
 
b
 
4
 
 
 
is involved in BM
anchorage via hemidesmosomes (Borradori, L., and A.
Sonnenberg. 1999. 
 
J. Invest. Dermatol
 
. 112:411–418).
We investigated a possible regulatory interplay be-
tween
 
 
 
a
 
3
 
b
 
1 and
 
 
 
a
 
6
 
b
 
4 in cell motility using HaCaT ke-
ratinocytes as a model. We found that 
 
a
 
6
 
b
 
4
 
 
 
antibodies
inhibit
 
 
 
a
 
3
 
b
 
1-mediated migration on Ln-5, but only
when migration is haptotactic (i.e., spontaneous or
stimulated by
 
 
 
a
 
3
 
b
 
1
 
 
 
activation), and not when chemo-
tactic (i.e., triggered by epidermal growth factor recep-
tor). Inhibition of migration by
 
 
 
a
 
6
 
b
 
4 depends upon
phosphoinositide 3-kinase (PI3-K) since it is abolished
by PI3-K blockers and by dominant-negative PI3-K,
and constitutively active PI3-K prevents haptotaxis. In
HaCaT cells incubated with anti–
 
a
 
6
 
b
 
4 antibodies, acti-
vation of PI3-K is mediated by
 
 
 
a
 
6
 
b
 
4-associated erbB-2,
as indicated by erbB-2 autophosphorylation and erbB-
2/p85 PI3-K coprecipitation. Furthermore, dominant-
negative erbB-2 abolishes inhibition of haptotaxis by
anti–
 
a
 
6
 
b
 
4 antibodies. These results support a model
whereby (a) haptotactic cell migration on Ln-5 is regu-
lated by concerted action of 
 
a
 
3
 
b
 
1 and
 
 
 
a
 
6
 
b
 
4 integrins,
(b)
 
 
 
a
 
6
 
b
 
4-associated erbB-2 and PI3-K negatively affect
haptotaxis, and (c) chemotaxis on Ln-5 is not affected
by 
 
a
 
6
 
b
 
4 antibodies and may require PI3-K activity. This
model could be of general relevance to motility of epi-
thelial cells in contact with BM.
Key words: erbB-2 • integrin • keratinocytes • lami-
nin-5 • phosphoinositide 3-kinase
 
Introduction
 
Epithelial cells are separated from the connective tissue by
 
the basement membrane (BM),
 
1
 
 a network of extracellular
matrix (ECM) polymers consisting of several laminin iso-
forms and type IV collagen, and connected by glycoproteins
such as nidogen (Timpl, 1996; Burgeson and Christiano,
 
1997). Keratinocytes are the dominant epithelial cell type
in the epidermis, a complex squamous epithelium that
forms the outer surface of the skin (Priestley, 1993) and
that is separated from the underlying dermis by the BM.
Contact of basal keratinocytes with the BM and their
cell–cell interactions are essential for proper function by
modulating cell polarity, proliferation, migration, and dif-
ferentiation (Adams and Watt, 1993; Burgeson and Chris-
tiano, 1997; Fuchs et al., 1997).
 
Cell–ECM or cell–cell adhesion are mediated by inte-
 
grins,
 
 
 
a
 
/
 
b
 
-heterodimeric
 
 
 
transmembrane glycoprotein re-
ceptors (Hynes, 1992). To reach high mechanical stability
and resist the frictional stresses the skin is subjected to, the
epidermal BM contains specialized anchoring complexes,
in addition to conventional integrin-mediated cell–ECM
linkages. Such anchoring complexes consist of hemidesmo-
somes, anchoring fibrils, and anchoring filaments with
laminin-5 (Ln-5) as a major component (Burgeson
 
 
 
and
Christiano, 1997). Basal keratinocytes express two Ln-5 in-
tegrin receptors,
 
 
 
a
 
3
 
b
 
1 and
 
 
 
a
 
6
 
b
 
4, which are recruited to dis-
tinct cell adhesion structures (Carter et al., 1990; Fuchs et
al., 1997). 
 
a
 
6
 
b
 
4 is a component of hemidesmosomes, link-
ing Ln-5 anchoring filaments on the outside of the cell with
the keratin filament network inside the cell (Borradori and
Sonnenberg, 1999), thus anchoring keratinocytes to the
BM. In contrast,
 
 
 
a
 
3
 
b
 
1 is recruited to focal contacts and
thereby links the ECM to components of the actin cyto-
skeleton, mediating cell spreading and migration (Carter
et al., 1990; Fuchs et al., 1997).
These two types of integrin-mediated adhesive junctions
are likely to transmit distinct molecular signals to cells.
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Since integrins are not equipped with enzymatic activity,
they need to associate with signaling molecules at the cell
surface (Schwartz et al., 1995; Giancotti, 1997; Porter and
Hogg, 1998; Giancotti and Ruoslahti, 1999, Schwartz and
Baron, 1999). 
 
a
 
3
 
b
 
1 is a typical integrin in terms of its
structure, containing a short (50 amino acid) cytoplasmic
 
b
 
1 tail (Sastry and Horwitz, 1993) implicated in activation
of focal adhesion kinase (FAK) (Schlaepfer et al., 1999;
Sieg et al., 2000). This latter event is coupled to the turn-
over of focal adhesions and modifications of the cytoskele-
ton (Giancotti and Ruoslahti, 1999; Schlaepfer et al., 1999;
Ren et al., 2000), both critical in cell migration (Horwitz
and Parsons, 1999). Furthermore,
 
 
 
a
 
3
 
b
 
1 is associated with
transmembrane-4 superfamily proteins such as CD81- or
CD151-forming complexes, which may regulate cell migra-
tion (Yauch et al., 1998; Testa et al., 1999).
In contrast, 
 
a
 
6
 
b
 
4 contains a unique
 
 
 
b
 
4 cytoplasmic do-
main (
 
z
 
1,000 amino acids) with no homology to other
known 
 
b
 
 
 
subunits, which mediates association with the
hemidesmosome cytoskeleton (Gil et al., 1994; Spinardi et
al., 1995) and contains a tyrosine activation motif that
upon phosphorylation can act as docking site for signaling
molecules containing Src homology 2 domains. In primary
keratinocytes, ligation of 
 
a
 
6
 
b
 
4 caused tyrosine phosphory-
lation of this motif, which recruited the adapter proteins
Shc and Grb2 and sequentially activated mitogen-acti-
vated protein kinase (MAP kinase) pathways, indicating a
role for 
 
a
 
6
 
b
 
4
 
 
 
in the regulation of keratinocyte prolifera-
tion (Mainiero et al., 1995, 1997). Furthermore, in breast
and colon carcinoma cells, 
 
a
 
6
 
b
 
4 was shown to activate
phosphoinositide 3-kinase (PI3-K), leading to increased
Matrigel invasion (Shaw et al., 1997).
Integrins not only use adapter proteins to interact with
signaling pathways, but they are also in direct physical in-
teraction with growth factor receptors (Miyamoto et al.,
1996). For example, 
 
a
 
v
 
b
 
3 integrin was reported to be as-
sociated with activated insulin and PDGF
 
b
 
 
 
receptors
(Schneller et al., 1997), and with vascular endothelial
growth factor receptor-2 (Soldi et al., 1999). Furthermore,
coimmunoprecipitation between
 
 
 
b
 
1 integrin and the re-
ceptor for epidermal growth factor was demonstrated
(Moro et al., 1998). Concerted action of integrins and
growth factor receptors may be crucial to tightly control
many biological processes, including cell motility during
wound repair, inflammation, and organogenesis. Cell mi-
gration triggered by adhesion receptors is referred to as
haptotaxis/haptokinesis, whereas cytokine and growth fac-
tor receptor-controlled motility is defined as chemotaxis/
chemokinesis. Ligands for these receptors may occur ei-
ther in a gradient (-taxis) or at a constant concentration
(-kinesis) (Wells, 2000).
During re-epithelialization of wounds, keratinocytes dis-
solve their stable attachment with the underlying BM and
migrate over a provisional matrix, continuously expressing
and depositing Ln-5 (Larjava et al., 1993; Yamada et al.,
1996). These observations suggested a role for Ln-5 as a
migratory substrate for keratinocytes. On the other hand,
Ln-5 was also reported to inhibit keratinocyte migration
and to promote establishment of cell anchoring hemides-
mosomal complexes in quiescent BM zones (Yamada et
al., 1996; O’Toole et al., 1997; Goldfinger et al., 1999).
How can the same ECM component mediate two such dif-
 
ferent cell behaviors like migration and anchorage? In
spite of a large body of information gathered by many lab-
oratories (Carter et al., 1990; Xia et al., 1996; DiPersio et
al., 1997; Fuchs et al., 1997; Mainiero et al., 1997; De Ar-
cangelis et al., 1999; Goldfinger et al., 1999; Nguyen et al.,
2000; Raghavan et al., 2000), there is still no satisfactory
answer to this question. Investigating this problem may
shed light on important processes such as wound healing
and may also provide insight on how cells in general regu-
late static adhesion versus migration.
In this study, we attempted to characterize the signaling
network that may regulate migration versus anchorage of
keratinocytes on Ln-5, via the two Ln-5 binding integrins,
 
a
 
3
 
b
 
1 and
 
 
 
a
 
6
 
b
 
4. As a model, we used the nontumorigenic,
spontaneously immortalized human keratinocyte cell line,
HaCaT. We report that integrin 
 
a
 
3
 
b
 
1 mediates both hap-
totactic and chemotactic migration on Ln-5 in HaCaT ke-
ratinocytes. However, integrin 
 
a
 
6
 
b
 
4 may inhibit hapto-
taxis on Ln-5, but not chemotaxis, via a pathway that
involves erbB-2 and PI3-K. Our results define distinct
types of keratinocyte migration on Ln-5, and point to pos-
sibly general mechanisms whereby 
 
a
 
3
 
b
 
1 and
 
 
 
a
 
6
 
b
 
4 are pre-
dominantly a migratory or an anchoring integrin, respec-
tively, for epithelia in contact with Ln-5.
 
Materials and Methods
 
Cell Lines, Constructs, and Retroviral Infections
 
HaCaT (Boukamp et al., 1988) and A431 cells (American Type Culture
Collection) were cultured in DMEM (4.5 g/liter glucose) containing 10%
FCS. Primary human keratinocytes were purchased from Clonetics and
cultured in completely defined medium (KGMD) according the manufac-
turer’s protocol. Passages 3 and 4 were used for migration assays.
 
 
 
Con-
structs encoding dominant-negative PI3-K (p85
 
D
 
iSH2-N and p85
 
D
 
SH2-C;
Rodriguez-Viciana et al., 1997) were from J. Downward (Imperial Cancer
Research Fund, London, UK) and the cDNA for the constitutive-active
PI3-K (MM
 
D
 
72cp3kFL; Jiang et al., 2000) was a gift from P.K. Vogt (The
Scripps Research Institute). Construct HER2VEK753A (Messerle et al.,
1994) encoding a dominant-negative erbB-2 variant was from N.E. Hynes
(Friedrich Miescher Institute, Basel, Switzerland). All cDNAs were sub-
cloned into the retroviral vector pLNCX (CLONTECH Laboratories,
Inc.). Virus production in PT67 packaging cells (CLONTECH Laborato-
ries, Inc.) and infection of HaCaT cells was performed as described in the
manufacturer’s protocol. A retroviral vector encoding enhanced green flu-
orescent protein was used to assess infection efficiency, which was at least
95% in each experiment.
 
Antibodies, Extracellular Matrix 
Molecules, and Reagents
 
The anti–CD151 monoclonal antibody (mAb) 1A5 (Testa et al., 1999) was
provided by J.P. Quigley (The Scripps Research Institute). mAbs 5C11
(anti–CD151; Yauch et al., 1998), TS2/16 (anti–
 
b
 
1; Hemler et al., 1984),
and A3-X8 (anti–
 
a
 
3; Weitzman et al., 1993) were gifts from M.E. Hemler
(Dana-Farber Cancer Institute, Boston, MA). mAb 12F1 (anti–
 
a
 
2; Pischel
et al., 1987) was provided by V.L. Woods, Jr. (University of California,
San Diego, San Diego, CA). Anti–b4 mAbs AA3 and S3-41 and rabbit
anti–a6 IgG 6845 were produced in our laboratory (Tamura et al., 1990;
Domanico et al., 1997). Commercially available integrin mAbs were ASC-1
(anti–a3; Chemicon), P1B5 (anti–a3; GIBCO BRL), GoH3 (anti–a6;
BD PharMingen), and P4C10 (anti–b1; GIBCO BRL). Rabbit anti–FAK
IgG (BD PharMingen) was used for immunoprecipitations and mAb anti–
FAK and anti–P-Tyr mAb PY20 (Transduction Laboratories) for West-
ern blotting. PI3-K subunit p110a was immunoprecipitated with mAb
N-20 (Santa Cruz Biotechnology, Inc.) and mAb to PI3-K p85 subunit for
Western blotting was purchased from Transduction Laboratories. Goat
anti–AKT1 IgG (C-20) was from Santa Cruz Biotechnology, Inc. and rab-
bit IgG to phosphorylated AKT was from New England Biolabs, Inc.Hintermann et al. Inhibition of Keratinocyte Haptotaxis by a6b4 467
erbB-2 was immunoprecipitated with mAb c-neu (Ab-2; Oncogene Re-
search Products) and analyzed in Western blots with mAb erbB-2 (Trans-
duction Laboratories). Rabbit anti–ERK1/2 IgG was from Santa Cruz
Biotechnology, Inc. and mAb to phosphorylated ERK1/2 was from New
England Biolabs, Inc. Anti–FLAG mAb M2 was from Sigma-Aldrich. Fab
fragments were generated by digestion of mAbs with 0.02 mg/ml papain
(Sigma-Aldrich). Human collage IV and bovine fibronectin were from
Sigma-Aldrich and Ln-5 deposited by the rat bladder carcinoma cell line
804G was purified in our laboratory. LY294002, PD98059, and tyrphostin
AG 825 were from Calbiochem and EGF was from Sigma-Aldrich.
Migration and Adhesion Assays
In Transwell migration assays, the underside of the filters (8.0 mm, pore
size; Costar) was coated at 48C overnight (ON) with 0.25 mg/ml Ln-5, 1 mg/
ml collagen IV, or 10 mg/ml fibronectin in PBS. Filters were washed twice
with PBS containing 0.2% Tween-20 (PBST), and then blocked with 5%
dry milk in PBST at room temperature (RT) for 2 h. Cells (HaCaT: 1.2 3
105 cells/filter; A431: 6 3 104 cells/filter, primary keratinocytes: 8 3 104
cells/filter) in migration medium, MM (culture medium without FCS)
were preincubated with antibodies, reagents or vehicle for 30 min at RT
before plating on filters that were washed twice with PBS after blocking.
EGF was added to the lower chamber only, whereas antibodies, reagents,
or vehicle were present in both chambers. Cells were maintained at 378C
for 5 h (primary keratinocytes for 15 h), and were then fixed and stained
using the LeukoStat kit (Fisher Scientific). The uncoated side of each fil-
ter was wiped with a cotton swap to remove cells that had not migrated
through the filter. Filters were viewed under bright-field optics and
stained cells were counted in eight fields (using a 203 objective) from
each of two filters for each condition, determining the mean number of
cells counted per field. Each experiment was done at least three times and
results are expressed as mean 6 SD of relative cell migration with non-
stimulated cells set as 1.
Scratch assays were performed in 24-well plates coated ON at 48C with
0.25 mg/ml Ln-5 in PBS. HaCaT cells (6 3 105/well) in MM were seeded
and incubated at 378C for 2 h. Then, cell layers were wounded with a plas-
tic pipet tip and washed three times with MM. The denuded surfaces were
recoated with 0.25 mg/ml Ln-5 in MM for 1 h at 378C. Cell layers were
washed again, TS2/16 (40 mg/ml) and/or EGF (1 ng/ml) were added, and
cells were incubated for 14 h at 378C. Photographs of identical locations
within each scratch were taken before, and 14 h after, addition of TS2/16,
EGF, or both stimuli.
Adhesion assays were performed as described by Goodwin and Pauli
(1995), with minor modifications. Microtiter 96-well plates were coated
with 1 mg/ml Ln-5, 1 mg/ml collagen IV, or 10 mg/ml fibronectin ON at
48C, washed twice with PBS, and blocked with 5% dry milk in PBS for 2 h.
Cells (6 3 104 cells/100 ml per well) in MM were preincubated with anti-
bodies for 30 min at RT before plating in wells that were washed twice
with PBS after blocking. EGF was added at the time of plating. Cells were
maintained at 378C for 30 min, and then 2 3 100 ml of Percoll floatation
medium [73 ml Percoll (density 1.13 g/ml; Amersham Pharmacia Biotech),
27 ml distilled water, and 900 mg NaCl] were added to each well. Adher-
ent cells were fixed for 15 min with 50 ml/well of 25% glutaraldehyde
(Sigma-Aldrich), washed with PBS, and stained with crystal violet (0.5%
in 20% MeOH) for 10 min. Excess dye was washed off with water and ab-
sorbance was measured at 595 nm. Bars represent mean absorbance 6 SD
of each condition tested in triplicates. All values have had background
substracted that represents cell adhesion to wells blocked with milk. Ex-
periments were done three times.
Biochemical Methods
Analysis of AKT-, erbB-2-, ERK1/2-, and FAK Phosphorylation, and erbB-2/
p85 Coimmunoprecipitation. Cell culture dishes (6 cm) were coated with 1
mg Ln-5/dish in PBS at 48C ON, and then prewarmed to 378C for 1 h. Se-
rum-starved cells (2–4 3 106) in MM were preincubated with antibodies
for 30 min at 378C in suspension before plating onto ligand-coated dishes.
(If cells were costimulated with TS2/16 and a second antibody, the latter
was added 5 min before TS2/16). After 30–60 min at 378C, the attached
cells were rinsed in PBS and lysed for 1 h on ice in 0.5 ml lysis buffer con-
taining 40 mM Tris, pH 7.5, 150 mM NaCl, 1% Triton X-100, 6 mM
EDTA, 100 mM NaF, 1 mM sodium orthovanadate, 10 mM sodium pyro-
phosphate, 1 mM PMSF, 10 mg/ml leupeptin, and one tablet/50 ml of
complete protease inhibitor cocktail (Roche Diagnostics Corp.). When
FAK was analyzed, the lysis buffer was supplemented with 10% glycerol,
1% sodium deoxycholate, and 0.1% SDS. Lysates were centrifuged at
maximum speed for 10 min in a microcentrifuge and antibodies were
added to the supernatant for 3 h at 48C on a rotatory shaker. Then, anti-
bodies were collected with protein-G Sepharose for 1 h at 48C on a rota-
tory shaker. The protein complexes were washed three times with ice-cold
lysis buffer before boiling in SDS-PAGE loading buffer. Proteins were
separated on acrylamide SDS-PAGE gels, blotted, and blots were incu-
bated with the primary antibodies diluted 1:2,000 in 5% milk in PBS con-
taining 0.1% Tween-20. For PY20, milk was replaced by 4% BSA. Each
sample was divided in two and analyzed for total AKT, FAK, or erbB-2
content or for phosphorylation or p85 content using the ECLplus system
(Amersham Pharmacia Biotech) and a STORM 860 Fluorimeter.
Integrin-erbB-2 Coimmunoprecipitations. Per sample, 3 3 107 cells were
lysed in lysis buffer as described above. Lysates were centrifuged at maxi-
mum speed for 10 min and supernatants were precleared for 1 h with pro-
tein-G Sepharose. Precleared supernatants were subjected to immunopre-
cipitation, SDS-PAGE, and Western blotting as described above.
PI3-K Enzyme Assay. PI3-K activity was measured according to Jiang et
al. (1998). In brief, cells and cell culture dishes were treated as described
above. Per dish, 4 3 106 cells were seeded and incubated for 1 h at 378C.
Then, cells were washed with PBS and lysed in lysis buffer for 30 min on
ice. Lysates were cleared by centrifugation and total protein concentration
was determined. Equal amounts of protein were incubated with precou-
pled protein-G Sepharose (precoupling: 2 mg anti–p110a antibody were
incubated with 50 ml protein-G Sepharose slurry for 1 h at RT) for 2 h at
48C. Protein complexes were washed twice with lysis buffer and three
times with 50 mM Hepes, pH 8.0, containing 160 mM NaCl and 10 mM
EDTA. Immunoprecipitates were resuspended in 50 ml kinase buffer [50
mM Hepes, pH 8.0, 5 mM MgCl2, 0.2 mg/ml phosphatidylinositol (1 mg/ml
stock, sonicated), and 60 mM ATP] and kinase reactions were started by
adding 20 mCi g-P32 ATP. After 10 min at RT, 60 ml of 1 N HCl were
added to stop the reactions, and lipids were extracted twice with 160 ml of
chloroform:methanol (1:1). Pooled extracts were evaporated in a Speed-
vac, resuspended in 10 ml chloroform, and subjected to thin layer chroma-
tography for 4 h at RT, using as running solvent a mixture of 65 ml
MeOH, 48 ml chloroform, 36 ml pyridine, 60 ml ethoxyquin, 6 ml H2O, 2.4
ml formic acid, 9.6 g boric acid, and 300 mg BHT. Before sample applica-
tion, thin layer chromatography plates were pretreated for 10 s in a mix-
ture of 81 ml H2O, 3 ml 5 N NaOH, 165 ml EtOH, and 2.27 g CDTA, and
then incubated at RT for 30 min and at 1008C for 10 min. Assays were an-
alyzed using a PhosphorImager.
Results
Integrin a3b1 Drives Haptotactic and Chemotactic 
Keratinocyte Migration on Ln-5
To study whether there is an interplay between  a3b1
and a6b4 integrins in regulating keratinocyte motility on
Ln-5, we first set up conditions under which haptotaxis
and chemotaxis of keratinocytes could be analyzed. In
Transwell chamber assays (Fig. 1 A), HaCaT cells
showed spontaneous migration towards Ln-5 that was
small but highly reproducible (Fig. 1 A). We consider
this spontaneous migration haptotactic since it appears
to be dependent on adhesion receptor/substrate interac-
tion, with no soluble factor added. Addition of TS2/16,
an “activating” anti–b1 integrin antibody (Humphries,
1996) caused a fivefold increase in migration (Fig. 1 A).
We consider this effect an enhancement of haptotactic
migration and used TS2/16 in most subsequent measure-
ments of haptotaxis since it amplifies signal-to-noise ra-
tio in the assay.
With EGF (1 ng/ml), a well-documented chemoattrac-
tant (Wells, 2000), there was an z25-fold increase in mi-
gration (Fig. 1 A). By definition, this increase is due to
chemotaxis. Combined exposure to TS2/16 and EGF re-
sulted in an additive effect (Fig. 1 A).
We further tested TS2/16 and EGF in the scratch assay
(Fig. 1 B), considered to be an in vitro model for kerati-The Journal of Cell Biology, Volume 153, 2001 468
nocyte migration occurring during wound healing (Wells,
2000). Scratch closure after 14 h was enhanced by treat-
ment with either TS2/16 or, more markedly, EGF (Fig. 1
B). With both agents together, an additive enhancing ef-
fect was detectable on keratinocytes migrating from the
edges (Fig. 1 B). These results support a distinction be-
tween TS2/16-enhanced and EGF-induced migration, indi-
cated by the Transwell assay.
In the Transwell assay, both TS2/16- and EGF-induced
HaCaT migration on Ln-5 required integrin  a3b1 since
migration was inhibited by antibodies to a3 (P1B5, A3-
X8) and b1 (P4C10) integrins, but not by control anti–a2
(12F1) antibody (Fig. 2, A and B). While the effect of
P1B5 and P4C10 antibodies may be indirect (i.e., a conse-
quence of adhesion inhibition; Fig. 2 C), A3-X8 antibody
is known to block migration but not adhesion (Weitzman
Figure 1. Haptotactic migration of HaCaT cells on Ln-5 can be enhanced by the stimulatory anti–b1 integrin antibody TS2/16. (A) Cell
migration assays were performed in Transwell chambers coated with 0.25 mg/ml Ln-5. HaCaT cells were incubated in suspension at RT
for 30 min in serum-free culture medium with or without TS2/16 (anti–b1, 40 mg/ml). Then, aliquots were seeded and the plates were in-
cubated at 378C for 5 h. EGF (1 ng/ml) was present in the lower chamber only, whereas TS2/16 was in both chambers. Migration was
quantified by counting cells migrated through filters (eight microscopic fields on each of two filters for each condition). In absence of
any stimuli, z12 cells were counted per microscopic field. In the bar graph, results are expressed as mean 6 SD (n 5 3) of relative cell
migration with nonstimulated cells set at 1. (Bottom) Micrographs of fixed and stained HaCaT cells migrated onto the lower surfaces of
Transwell filters (bar, 50 mm). (B) Effects of TS2/16 and EGF in scratch assays. In this assay, cells migrate from the edges of “scrape-
wounded” monolayers (arrows) to cover the denuded surface (space between arrows). Scrape wounds were made in serum-free HaCaT
cultures plated on Ln-5. Denuded surfaces were recoated with Ln-5 and the wounded cultures were allowed to re-epithelialize for 14 h
at 378C in the presence of TS2/16 (anti–b1, 40 mg/ml), EGF (1 ng/ml), or both stimuli. Micrographs of wounded, nonfixed cell layers at 0
and 14 h after treatment (bar, 100 mm).Hintermann et al. Inhibition of Keratinocyte Haptotaxis by a6b4 469
et al., 1993), indicating that HaCaT migration on Ln-5, un-
der our conditions, is carried out by integrin a3b1. Fur-
thermore, antibodies to CD151, a tetraspanin stoichiomet-
rically associated with a3b1 (Yauch et al., 1998; Testa et
al., 1999) also blocked migration (Fig. 2 A), but had little
effect on adhesion (C).
Preincubation with TS2/16 increased adhesion to Ln-5
approximately twofold, indicating that TS2/16 induces an
increase in a3b1 avidity for Ln-5. Furthermore, an anti-
body to  a3 (P1B5) almost completely blocked this en-
hanced adhesion (Fig. 2 C), supporting a3b1 dependence.
On the other hand, no effect of EGF in adhesion assays
was observed (Fig. 2 C), suggesting no EGF influence on
a3b1 avidity.
To further characterize TS2/16-induced migration, we
tested the involvement of two possible  a3b1 effectors,
FAK and extracellular signal-regulated kinase (ERK)
MAP kinase. All b1 integrins share the ability to promote
assembly of focal adhesions and to activate FAK (Gian-
cotti, 1997). Indeed, in cells plated on Ln-5, tyrosine phos-
phorylation of FAK was increased when compared with
cells plated on plastic (Fig. 3 A). This phosphorylation
was amplified in the presence of TS2/16, correlating with
integrin activation and stimulation of adhesion and migra-
tion by this antibody. TS2/16-induced FAK phosphoryla-
tion was also seen in cells kept in suspension. This is
consistent with the finding that TS2/16 is an activating
antibody that induces changes in integrin shape in a
ligand-independent manner (Humphries, 1996). As a con-
trol, antibodies to a6b4 had no influence on FAK phos-
phorylation (Fig. 3 A). A3-X8, the anti–a3 antibody that
blocked migration but had no influence on adhesion, was
without effect on FAK phosphorylation, neither when
added alone nor together with TS2/16. Therefore, inhibi-
tion of migration by A3-X8 was not due to decreased
phosphorylation of FAK.
MAP kinases, such as ERK1 and ERK2, are known to
play a stimulatory role in regulation of cell migration
(Lauffenburger and Horwitz, 1996; Klemke et al., 1997).
Therefore, we tested for the involvement of these enzymes
in our system. The ERK kinase (MEK)-specific inhibitor
PD98059 prevented TS2/16-stimulated HaCaT migration
on Ln-5 (Fig. 3 B), suggesting that ERK1 and ERK2 are
possible mediators of haptotaxis. In contrast, PD98059 had
no effect in adhesion assays (data not shown), indicating
that ERK1/2 are not involved in regulating cell adhesion to
Ln-5. Next, ERK1/2 phosphorylation was analyzed in
HaCaT cells plated on plastic or on Ln-5 in the presence of
anti–integrin antibodies. An increase in ERK1/2 phos-
phorylation was detected on Ln-5 when compared with the
plastic control (Fig. 3 C). Addition of TS2/16 enhanced
phosphorylation of ERK1/2 further, whereas A3-X8 had a
slightly inhibitory effect. If cells were treated with TS2/16
and A3-X8 together, the stimulatory effect of TS2/16 was
blocked by A3-X8. Therefore, inhibition of TS2/16-induced
migration by A3-X8 may be due to decreased ERK1/2 acti-
vation in the presence of A3-X8. As a control, antibodies to
a6b4 had no influence on ERK1/2 phosphorylation, nei-
ther when added alone nor in the presence of TS2/16.
These results suggest an involvement of ERK1/2, in the
regulation of a3b1 controlled keratinocyte haptotaxis on
Ln-5.
Figure 2. Integrin a3b1 mediates both TS2/16-stimulated hapto-
taxis and EGF-stimulated chemotactic migration in HaCaT kerati-
nocytes. (A) Haptotactic migration of HaCaT cells was stimulated
with the anti–b1 antibody TS2/16, as in Fig. 1 A. Where indicated,
cells were preincubated at RT for 15 min with P1B5 (anti-a3, 10
mg/ml), P4C10 (anti–b1, 1:50 dilution), A3-X8 (anti–a3, 10 mg/ml),
5C11 (anti–CD151, 20 mg/ml), 1A5 (anti–CD151, 50 mg/ml), or
12F1 (anti–a2, 40 mg/ml) antibodies. Migration was quantified as
described in Fig. 1 A. (B) Inhibitory effect of A3-X8 antibody
(anti–a3, 10 mg/ml) on HaCaT cell migration stimulated either by
EGF alone or by EGF and TS2/16 together. Migration assays were
performed as described in Fig. 1 A. (C) Adhesion assays of HaCaT
cells pretreated, as indicated, either with antibodies (as described
in A) or with EGF (1 ng/ml added at the time of seeding). (Bot-
tom, gray bars) Cells were TS2/16 stimulated in addition to treat-
ment with indicated antibodies or EGF. Tests were performed
with aliquots seeded in triplicates in Ln-5–coated (1 mg/ml) 96-well
plates. Cells were allowed to adhere for 30 min at 378C, and then
nonadherent cells were removed, and adherent cells were fixed
and stained. Results of no less than three representative experi-
ments are expressed as mean absorbance at 595 nm 6 SD.The Journal of Cell Biology, Volume 153, 2001 470
a6b4 Inhibits Haptotactic Cell Migration via 
Stimulation of PI3-K
We then tested the role of  a6b4 in haptotactic kerati-
nocyte migration, using chemotactic migration as a com-
parison. Spontaneous haptotactic migration on Ln-5 was
readily blocked by antibodies to the integrin subunits a6
(GoH3) or b4 (AA3) (Fig. 4 A). TS2/16-enhanced migra-
tion was equally inhibited by antibodies to a6b4, including
S3-41, which recognizes the a6b4 heterodimer. This inhi-
bition was induced also by the Fab fragments of S3-41 and
AA3, suggesting it did not require a6b4 clustering but sim-
ply binding of the antibodies. This a6b4 inhibitory effect
was Ln-5 specific since TS2/16 was also able to enhance
migration on collagen IV, but in this case it was not inhib-
ited by GoH3 (Fig. 4 A).
In contrast to haptotaxis, EGF-induced chemotactic mi-
gration was not affected by GoH3 (Fig. 4 B). If both EGF
and TS2/16 were added, GoH3 showed partial inhibition
(Fig. 4 B), presumably corresponding to that part of mi-
gration that was TS2/16 induced. Thus, a6b4 can influence
a3b1 controlled migration, but only when it is haptotactic.
Neither anti–a6b4 antibodies (AA3 and GoH3) had any
influence on adhesion to Ln-5, nor did they inhibit the in-
creased adhesiveness induced by TS2/16 (Fig. 4 C). There-
fore, like for A3-X8, the observed decrease in migration
may be a direct effect of a6b4 on signals regulating motil-
ity in HaCaT cells.
Next, we were therefore interested in identifying a can-
didate signaling molecule responsible for a6b4-linked
downmodulation of haptotaxis on Ln-5. PI3-K is one such
likely candidate because, in breast carcinoma cells, PI3-K
was shown to be activated by the anti–a6 antibody GoH3
(O’Connor et al., 1998). Wortmannin, a PI3-K blocker,
abolished inhibition of Ln-5 migration by anti–a6b4 anti-
bodies (data not shown). LY294002, a more stable and
specific PI3-K blocker, showed stronger effects (Fig. 5 A)
and was preferred in further experiments. This finding
suggests that downstream of a6b4, PI3-K may mediate in-
hibition of a3b1-dependent haptotactic migration. In con-
trast, a decrease in migration by A3-X8 is not PI3-K de-
pendent since LY294002 did not overcome the inhibitory
effect of this antibody (Fig. 5 A).
To confirm that a6b4 is capable of activating PI3-K in
HaCaT cells, we used a lipid kinase assay to detect a6b4-
induced PI3-K activation. Endogenous PI3-K isolated with
Figure 3. Analyses of FAK and ERK1/2 as candidate down-
stream signaling molecules in  a3b1-dependent haptotaxis. (A)
FAK phosphorylation. Changes in FAK phosphorylation state
relative to cells plated on Ln-5 are observed after TS2/16, but not
A3-X8 or anti–a6b4 antibody treatment. Cells were incubated at
378C in suspension for 30 min with TS2/16 (anti–b1, 40 mg/ml)
and/or GoH3 (anti–a6, 15 mg/ml), AA3 (anti–b4, 40 mg/ml), and
A3-X8 (anti–a3, 10 mg/ml) before seeding in noncoated or coated
(1 mg Ln-5/dish) dishes and incubation for 30 min at 378C. Total
cell lysates were subjected to immunoprecipitation with an anti–
FAK antibody and Western blotting with antibodies to phospho-
tyrosine (P-Tyr) or FAK. Ratios of phosphorylated FAK to total
FAK protein is quantified in the bar graph below. Mean 6 SD
(n 5 3) of relative FAK phosphorylation intensity and one repre-
sentative experiment is depicted. (B) Inhibition of TS2/16-induced
(gray bars) HaCaT haptotaxis by MEK inhibitor PD98059 (PD)
on Ln-5–coated filters. Cells were pretreated with PD (50 mM) or
vehicle (DMSO). Migration assays were performed and results
expressed as in Fig. 1 A. (C) Analysis of ERK1/2 phosphoryla-
tion. ERK1/2 phosphorylation relative to cells plated on Ln-5
alone is increased by TS2/16, and this stimulation is blocked by
A3-X8. Antibodies to a6b4 have no influence on ERK1/2 activa-
tion. Phosphorylated ERK1/2 bands (P-ERK1/2) are shown
above total ERK1/2 protein bands (ERK1/2), and their ratio is
quantified in the bar graph below. Mean 6 SEM (n 5 3) of rela-
tive ERK1/2 phosphorylation intensity and one representative
experiment is depicted. Assay conditions as in A, except that
anti–ERK1/2 or anti–phospho-ERK1/2 antibodies were used.Hintermann et al. Inhibition of Keratinocyte Haptotaxis by a6b4 471
a p110a-specific antibody showed increased enzymatic ac-
tivity in cells plated on anti–a6 (GoH3) or anti–b4 (AA3)
antibodies, but not on anti–CD151 antibody 1A5, anti–a3
(ASC-1), or anti–b1 (TS2-16) integrin antibodies (Fig. 5
B), suggesting  a6b4 integrin-specific PI3-K activation.
Production of PI3-P was also increased in cells plated on
Ln-5 compared with cells in suspension (Fig. 5 B).
As additional proof that binding of AA3 or GoH3 to
a6b4 results in activation of PI3-K, we tested activation of
the downstream effector of PI3-K, AKT (Kandel and Hay,
1999). Indeed, phosphorylation of AKT immunoprecipi-
tated from cells plated on Ln-5 was higher than in cells
plated on plastic, and was further increased in the pres-
ence of AA3 or GoH3 (Fig. 5 C).
These results suggest that, in our system, PI3-K is an ef-
fector for a6b4 inhibition of haptotactic migration. To
confirm this conclusion, dominant-negative and constitu-
tive-active PI3-K variants were transiently overexpressed
in HaCaT cells. To this end, we used a retroviral expres-
sion system, since other methods, like calcium phosphate
coprecipitation or liposome-mediated transfection, failed
because HaCaT cells were not able to migrate after these
treatments. In HaCaT cells infected with retrovirus encod-
ing a dominant-negative regulatory subunit p85DiSH2-N,
migration could still be stimulated by TS2/16. However,
inhibition of migration by AA3 was no longer possible
(Fig. 6). Thus, the anti–b4 antibody can only act as inhibi-
tor if a functional PI3-K is available in these cells. (Similar
results were found with p85DiSH2-C and GoH3, respec-
tively, data not shown.) In contrast, overexpression of a
constitutive-active catalytic subunit p110myr abolished the
stimulatory effect of TS2/16 on migration (Fig. 6).
Taken together, these results support the concept that,
in HaCaT cells, a6b4-dependent inhibition of haptotactic
migration operates via a class IA PI3-K pathway, with
p110a as the responsible catalytic subunit.
PI3-K Inhibits Haptotactic Migration, but Plays a 
Stimulatory Role in Chemotactic Migration
In apparent disagreement with our findings, PI3-K has
been invariably associated with a stimulatory role in mi-
gration (Derman et al., 1997; Keely et al., 1997; Gambal-
etta et al., 2000). To the best of our knowledge, though,
most reports referred to chemotactic migration (for re-
view, see Wells, 2000), rather than haptotaxis. Indeed,
in our system, PI3-K is involved in stimulating HaCaT
cell migration when this is of the chemotactic type, as
indicated by inhibition of EGF-induced migration by
LY294002 (Fig. 7 A). On the other hand, LY294002 had
no effect on haptotactic, TS2/16-induced migration (Fig. 7
B). On collagen IV, another ECM component, HaCaT
cells stimulated with TS2/16 behaved exactly as on Ln-5.
In summary, PI3-K can play an alternative role in HaCaT
motility: if migration is chemotactic, then PI3-K plays a
stimulatory role; if migration is haptotactic, then PI3-K
plays an inhibitory role.
To ensure that these findings are general to kerati-
nocytes, rather than HaCaT specific, migration experi-
ments were also performed with primary keratinocytes
and with A431, an epidermoid squamous carcinoma cell
line. Similar to HaCaT, primary keratinocytes showed in-
Figure 4. Integrin a6b4 antibodies inhibit a3b1-dependent hapto-
tactic, not chemotactic migration, and have no effect on adhesion
in HaCaT cells. (A) HaCaT haptotaxis was stimulated with TS2/16
as described in Fig. 1 A. Where indicated, cells were also pre-
treated as in Fig. 2 A with S3-41 antibody (anti–a6b4, 40 mg/ml),
S3-41 Fab fragments (13.4 mg/ml), GoH3 (anti–a6, 15 mg/ml), AA3
(anti–b4, 40 mg/ml), or AA3 Fab fragments (13.4 mg/ml). Tran-
swell filters were coated with either 0.25 mg/ml Ln-5 or 1 mg/ml col-
lagen IV. Migration assays performed and results expressed as in
Fig. 1 A. (B) Anti–a6 antibody GoH3 (15 mg/ml) has no effect on
HaCaT chemotactic migration stimulated by EGF (1 ng/ml), but
inhibits partially migration of cells stimulated with a combination
of EGF and TS2/16 (40 mg/ml). Migration assays performed and
results expressed as in Fig. 1 A. (C) Anti–a6b4 antibodies (GoH3,
15 mg/ml, or AA3, 40 mg/ml) have no effect on HaCaT cell adhe-
sion. (Bottom, gray bars) Cells pretreated with TS2/16 in addition
to indicated antibodies (as in Fig. 2 C). Antibody treatment of
cells, adhesion assays, and result analyses were performed as de-
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creased migration in the presence of TS2/16 (Fig. 8 A).
This stimulation was inhibited by antitetraspanin antibody
1A5 and by GoH3 (anti–a6). A431 cells showed an z17-
fold higher basal migration than HaCaT (data not shown).
Nonetheless, similar to HaCaT, TS2/16 stimulated A431
migration on Ln-5 approximately twofold, and this in-
crease was inhibited by antitetraspanin antibody 1A5,
anti–a6b4 integrin antibody S3-41, and by GoH3 (anti–a6)
(Fig. 8 B). The a6b4-mediated inhibition of A431 motility
also appeared to be linked to a PI3-K pathway since
LY294002 abolished it (Fig. 8 B). (Note that the effect of
LY294002 could not be analyzed in primary keratinocytes
since they did not survive treatment with this reagent.)
Furthermore, like HaCaT, A431 migration in the presence
of TS2/16 increased on collagen IV (Fig. 8 B).
These results showed that our findings on HaCaT cells
are likely to be of general applicability to keratinocytes.
We then carried out further investigations on possible
links between integrin a6b4 and PI3-K that may inhibit
a3b1-dependent haptotactic migration. Figure 5. PI3-K blocker LY294002 releases inhibition of HaCaT
haptotaxis by anti–a6b4 antibodies. Anti–a6b4 antibodies acti-
vate PI3-K in HaCaT cells. (A) Haptotactic migration was stimu-
lated in HaCaT cells by treatment with TS2/16 (as in Fig. 1 A).
Where indicated, cells were pretreated with the PI3-K blocker
LY294002 (LY) (20 mM) or vehicle (DMSO), GoH3 (anti–a6, 15
mg/ml), AA3 (anti–b4, 40 mg/ml), or A3-X8 (anti–a3, 10 mg/ml).
Migration assays performed and results expressed as in Fig. 1 A.
(B) PI3-K activity assay. HaCaT cells were allowed to adhere to
dishes coated with Ln-5 (1 mg) or indicated antibodies (GoH3, 30
mg; AA3, 50 mg; 1A5, 50 mg; TS2/16, 50 mg; ASC-1, 30 mg) or
were kept in suspension (control) for 1 h. Total cell lysates were
prepared and equivalent amounts of total proteins were subjected
to immunoprecipitation and kinase assay. Phosphorylated lipids
were resolved by thin layer chromatography. Mean 6 SEM (n 5
3 or 4) of percentage of control activity and one representative
chromatogram are depicted. PI(3)P, phosphatidylinositol 3-phos-
phate. (C) AKT phosphorylation. After pretreatment with anti-
bodies (GoH3, 15 mg/ml, or AA3, 40 mg/ml) for 30 min, cells were
seeded in dishes coated with Ln-5 (1 mg/dish). After incubation
for 30 min at 378C, total cell lysates were prepared and subjected
to immunoprecipitation with an anti–AKT antibody and Western
blotting with antibodies to phosphorylated AKT (P-AKT) or
AKT (AKT). Mean 6 SEM (n 5 3) of relative AKT phosphory-
lation intensity and one representative experiment is shown.
Figure 6. Dominant-negative PI3-K p85 subunit abolishes inhibi-
tion of haptotactic migration by a6b4, while constitutive active
PI3-K p110 subunit abolishes stimulation of haptotactic migration
by TS2/16. HaCaT cells infected with retrovirus encoding a domi-
nant-negative regulatory PI3-K domain (p85 DiSH2-N) or a consti-
tutive-active catalytic PI3-K domain (p110myr) or mock infectants
were subjected to haptotactic migration assays as described in
Fig. 1 A. Data are mean 6 range of two duplicate experiments.
Nonstimulated cells were set as 1. *Not significantly different val-
ues, P . 0.05; Student’s t test. **Significantly different values,
P , 0.05. (Right) Expression of infected cDNAs confirmed by
immunoblotting of equal amounts of total cell lysates (antibodies
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erbB-2 May Be a Signaling Link between a6b4 and PI3-K
Class IA PI3-K enzymes are stimulated by receptors with
intrinsic protein tyrosine kinase activity (Wymann and
Pirola, 1998). Integrin a6b4 has no such activity, but it was
shown to be associated with the EGF receptor family
member erbB-2 in human mammary and ovarian carci-
noma cell lines (Falcioni et al., 1997). This interaction may
provide a signaling link between a6b4 and PI3-K. To ad-
dress this possibility, we first tested whether a6b4 is physi-
cally associated with erbB-2 in HaCaT cells. Indeed, in
coimmunoprecipitation experiments, erbB-2 was precipi-
tated with the anti–a6 antibody GoH3 and with AA3
(anti–b4), but not with the anti–b1 antibody TS2/16 (Fig. 9
A). In addition, the presence of a6b4/erbB-2 complexes
was supported by the fact that an antibody to erbB-2 pre-
cipitated integrin subunit a6 (Fig. 9 A).
If erbB-2 is necessary for a6b4-mediated PI3-K activa-
tion, stimulation with AA3 or GoH3 should result in
erbB-2 autophosphorylation, leading to subsequent re-
cruitment of the PI3-K regulatory domain p85. Phosphory-
lation of erbB-2 was higher in cells plated on Ln-5 than on
uncoated dishes. This effect was further increased when
cells were treated with AA3 or GoH3, whereas TS2/16 was
without effect (Fig. 9 B). Treatment with GoH3 was also
effective in the absence of ECM ligand, as seen in cells
stimulated in suspension.
Next, we investigated physical interactions between
erbB-2 and PI3-K. Coimmunoprecipitation experiments
showed that stimulation with GoH3 leads to increased as-
sociation of p85 with erbB-2 (Fig. 9 C), providing a means
for triggering increased PI3-K activity.
To substantiate the role of erbB-2 in our system, the ef-
fect of the erbB-2–specific inhibitor Tyrphostin AG 825
(Tsai et al., 1996) was investigated in migration assays.
This compound abolished the inhibitory effect of AA3 and
GoH3 on TS2/16-stimulated migration on Ln-5 (Fig.
10 A), indicating that the presence of functional erbB-2
is required for a6b4-mediated inhibition of TS2/16-
induced haptotaxis. Finally, the involvement of erbB-2
was also demonstrated by the finding that TS2/16-stimu-
Figure 7. PI3-K blocker LY294002 inhibits chemotaxis but not
haptotaxis in HaCaT cells. (A) Chemotactic migration was stimu-
lated with EGF, and cells were pretreated with PI3-K blocker
LY294002 or vehicle (DMSO) as in Figs. 1 A and 3 B, respec-
tively. (B) Haptotactic migration was performed as in Fig. 1 A on
Transwell filters coated with Ln-5 (0.25 mg/ml) or collagen IV (1
mg/ml). HaCaT cells were treated (gray bars) with TS2/16 (anti–
b1, 40 mg/ml) to stimulate haptotaxis. Where indicated, cells were
pretreated as in A. Results are expressed as mean 6 SD (n 5 3)
of relative cell migration with nonstimulated cells set as 1.
Figure 8. Primary keratinocytes and A431 epidermoid carcinoma
cells behave like HaCaT cells: TS2/16 enhances haptotaxis, anti–
a6b4 antibodies inhibit TS2/16-induced haptotaxis, and PI3-K
blockers abolish the anti–a6b4 antibody-mediated inhibition of
haptotaxis. (A) Primary keratinocytes were stimulated to migrate
haptotactically with TS2/16 antibody (gray bars) as in Fig. 1 A.
Where indicated, they were pretreated with antibodies to a6
(GoH3, 15 mg/ml) or CD151 (1A5, 50 mg/ml). Migration was per-
formed on filters coated with Ln-5 (0.5 mg/ml) and quantified after
15 h at 378C as in Fig. 1 A. Results pooled from two experiments
are expressed as in Fig. 1 A. (B) A431 cells were tested in hapto-
tactic migration assays performed as in Figs. 1 A and 4 A, except
that half the number of cells/well was seeded (6 3 105 cells/ml).The Journal of Cell Biology, Volume 153, 2001 474
lated HaCaT cells overexpressing a dominant-negative
erbB-2 variant could no longer be blocked with AA3 when
migrating on Ln-5 (Fig. 10 B).
In summary, we provide evidence that erbB-2 mediates
a6b4-controlled stimulation of PI3-K in HaCaT cells.
Discussion
In this paper, we investigated integrin-dependent signaling
that regulates haptotactic migration of keratinocytes on
one of their natural substrates, Ln-5. We obtained results
that may be useful to understand the haptotactic compo-
nent of migration in epithelial cells in general (e.g., during
tissue remodeling and regeneration) or in BM crossing by
transformed epithelial cells.
Our conclusions can be summarized as follows: (a) one
of two integrins that bind Ln-5, a3b1, drives haptotactic as
well as chemotactic migration of keratinocytes; (b) the
other Ln-5–binding integrin, a6b4, inhibits haptotactic,
but not chemotactic migration; (c) a6b4 interferes with ke-
ratinocyte haptotaxis via stimulation of PI3-K; (d) PI3-K
inhibits only haptotactic migration, whereas it has a stimu-
latory role in chemotactic migration; (e) erbB-2 is a signal-
ing link to PI3-K for the inhibition of a3b1-dependent
haptotaxis by a6b4; and (f) the interplay between integrins
a3b1 and a6b4 affects migration, but not adhesion.
These conclusions are based on results obtained in
Transwell migration assays, in which HaCaT cells showed
haptotactic migration spontaneously (to a low level) or af-
ter stimulation with the integrin-activating antibody TS2/
16 (to a higher level), as well as chemotactic migration af-
ter exposure to EGF. In all cases, a3b1 was the integrin-
mediating migration as concluded from antibody blocking
experiments. Of particular importance to this conclusion
were data accumulated with anti–CD151 and A3-X8 anti-
bodies, which interfere with  a3b1-dependent migration,
not adhesion (Weitzman et al., 1993; Yauch et al., 1998;
Testa et al., 1999). Interestingly, we found that A3-X8 an-
tibody may block migration by inhibiting a3b1-dependent
ERK stimulation, but not FAK phosphorylation.
The distinction between haptotactic (i.e., controlled by
adhesion receptors) and chemotactic (i.e., controlled by
growth factor receptors) migration is physiologically rele-
vant, but it is sometimes overlooked. In physiopathologi-
cal situations such as wound healing and inflammation
(Martin, 1997; Wells, 2000), chemotaxis induced by che-
mokine gradients may dominate. On the other hand, hap-
totaxis may be more relevant when tumor cells traverse
the BM (Damsky and Werb, 1992). In this study, we took
Figure 9. a6b4-associated erbB-2
becomes phosphorylated and
binds PI3-K p85 subunit in the
presence of anti–a6b4 antibod-
ies. (A) Coimmunoprecipita-
tion of erbB-2 with a6b4. (Left)
erbB-2 (arrow) is present in
lanes corresponding to HaCaT
lysates subjected to immunopre-
cipitation with antibodies to
erbB-2,  a6-integrin (GoH3), or
b4-integrin (AA3), but not to
b1-integrin (TS2/16). Immuno-
complexes were analyzed by
Western blotting with an anti-
body to erB-2. *Background
band present in all lanes. (Right)
a6 reactivity is present in cell ly-
sates subjected to immunopre-
cipitation with antibodies to
erbB-2 or a6-integrin (GoH3),
but not with control anti-MHCI
antibody W6/32. Immunocom-
plexes were analyzed by West-
ern blotting with an antibody to
the  a6-integrin. (B) erbB-2
phosphorylation in response to
Ln-5 and a6b4 antibodies
(GoH3 and AA3), but not anti–
b1 antibody TS2/16. Ratio of
phosphorylated bands (P-erbB-2)
versus protein bands (erbB-2) is
represented in the bar graph be-
low (mean 6 SD, n 5 3). Assay conditions are as in Fig. 3, except that an antibody to erbB-2 was used for immunoprecipitations and
Western blots. (C) Coimmunoprecipitation of erbB-2 with p85 PI3-K. The PI3-K subunit p85 is coprecipitated by anti–erbB-2 only in
cells that were GoH3 treated. Cells were pretreated with GoH3 (15 mg/ml) for 30 min at 378C, and then seeded on dishes coated with
Ln-5 (1 mg/dish). After incubation for 60 min, total cell lysates were prepared and subjected to immunoprecipitation with an anti–erbB-2
antibody and Western blotting with antibodies to p85 PI3-K or erbB-2. Representative of three experiments.Hintermann et al. Inhibition of Keratinocyte Haptotaxis by a6b4 475
advantage of the well-known b1 integrin-activating anti-
body TS2/16 to enhance spontaneous haptotactic migra-
tion of keratinocytes on Ln-5 (as well as collagen IV),
producing Transwell assay results with much better sig-
nal-to-noise ratio. While the exact mechanisms underlying
activation of integrins by TS2/16 are not well defined, this
antibody presumably functions by inducing changes in in-
tegrin shape, stabilizing a conformation that resembles the
ligand-bound conformation of the integrin (Humphries,
1996; Bazzoni and Hemler, 1998). Consequently, avidity
for ligand is increased, as measured in adhesion assays.
In contrast, in EGF-treated cells, a3b1 did not appear to
be activated, as indicated by unchanged avidity in adhesion
assays. Nonetheless, EGF-stimulated cells migrated more
efficiently than TS2/16-stimulated ones, consistent with the
fact that EGF acts at several levels within cells, possibly
lowering their threshold for motility (Wells, 2000). There-
fore, it appears that integrin activation may be a regulatory
step for haptotactic, not chemotactic migration.
Another indication that TS2/16 and EGF induce two
distinct types of migration is that they are differentially af-
fected by various inhibitors. In this regard, the difference
most relevant to this work, and perhaps keratinocyte biol-
ogy, concerns sensitivity to anti–a6b4 antibodies. Thus, we
found that antibodies to a6b4 inhibited TS2/16-induced
migration, but not EGF-stimulated migration. This finding
suggests a role for a6b4 in downregulating a3b1-depen-
dent haptotactic migration on Ln-5. Indeed, a6b4 is well
known to play a major role in protein complexes called
hemidesmosomes, which anchor basal epidermal cells to
the underlying basement membrane (Borradori and Son-
nenberg, 1999). Therefore, it is not surprising that a6b4
may favor immobilization of cells to the substrate. This
seems to be accomplished by inhibiting a3b1-dependent
haptotactic migration at the level of signaling rather than
by stabilizing adhesion, since anti–a6b4 antibodies did not
increase cell adhesion to Ln-5. Furthermore, anti–a6b4
antibodies block migration via a different pathway than
A3-X8, because they do not inhibit ERK stimulation.
Recent studies described a6b4 as the integrin-mediating
carcinoma cell migration on Ln-1 and in Matrigel invasion
assays (Rabinovitz and Mercurio, 1997; Shaw et al., 1997;
Gambaletta et al., 2000). These results seemingly contra-
dict our findings, as well as the anchoring role of a6b4 in
epidermis. However, in those assays, a6b4-dependent mo-
tility was only observed in chemotactic, but not in hapto-
tactic migration assays (O’Connor et al., 1998). Further-
more, it depended strictly upon the overexpression of
a6b4 (Shaw et al., 1997; O’Connor et al., 1998; Gambal-
etta et al., 2000). In our system, we found no evidence that
a6b4 supported motility. Instead, keratinocyte migration
(either type) on Ln-5 could be entirely accounted for by
a3b1. Differences in cell types and ECM substrates may
be responsible for these discrepancies, which need to be
solved by further studies.
As mentioned above, the interference by a6b4 in a3b1
migration appears to occur at the level of signaling. The
phenomenon that occupancy of one integrin, here a6b4,
can suppress the function of another integrin, here a3b1,
has been observed in several other cell systems and is a
concept appreciated as trans-dominant inhibition (Diaz-
Gonzalez et al., 1996). For example, anti–avb3 antibodies
suppress  a5b1-dependent phagocytosis (Blystone et al.,
1994), ligation of a4b1 inhibits a5b1-dependent expres-
sion of metalloproteinases (Huhtala et al., 1995), and a3b1
inhibits fibronectin and collagen IV receptor functions
(Hodivala-Dilke et al., 1998). In general, trans-dominant
inhibition involves changes in integrin conformation and
requires integrin-linked signal transduction cascades (Sas-
try and Horwitz, 1993; Diaz-Gonzalez et al., 1996, Hughes
et al., 1997). It remains to be seen which mechanisms apply
to the a6b4-initiated inhibition of a3b1 migration.
As an initial attempt to identify such mechanisms, we
began to analyze signaling pathways downstream of a6b4
responsible, in our system, for the inhibition of a3b1 mi-
gration. Several lines of evidence implicated PI3-K. First,
LY294002, a specific inhibitor of PI3-K, abolished the in-
hibitory effect of anti–a6b4 antibodies on TS2/16-induced
haptotaxis in HaCaT cells, as well as A431. Second, consti-
Figure 10. Analyses of erbB-2 as a link between a6b4 and PI3-K
for inhibiting a3b1-dependent haptotaxis. (A) HaCaT haptotaxis,
induced as in Fig. 1 A, is blocked by anti–a6b4 antibodies, but not
in the presence of AG826 (100 nM), a specific erbB-2 inhibitor.
Cells were treated with antibodies, AG826 or vehicle (DMSO) as
in Fig. 3 B. Assays performed and result analyses as in Fig. 1 A.
(B) HaCaT cells infected with retrovirus encoding dominant-neg-
ative erbB-2 (HER2VEK753A), but not mock infectants, fail to
display inhibition of haptotaxis by anti–a6b4 antibodies. Migra-
tion assays with TS2/16 stimulation performed as in Fig. 6. Data
shown are mean values 6 range of two duplicate experiments,
with nonstimulated cells set at 1. *Significantly different values,
P , 0.1, Student’s t test. (Right) Expression of infected cDNA
confirmed by immunoblotting of equal amounts of total cell ly-
sates with an anti–erbB-2 antibody.The Journal of Cell Biology, Volume 153, 2001 476
tutive-active PI3-K prevented TS2/16-induced haptotaxis,
and dominant-negative PI3-K prevented inhibition of hap-
totaxis by anti–a6b4 antibodies. Third, phosphatidylinosi-
tol 3-phosphate production by PI3-K, identified as class IA
p110a isoform, was exclusively increased in cells stimu-
lated with anti–a6b4 antibodies, whereas anti–a3b1 anti-
bodies had no effect. Fourth, phosphorylation of AKT, a
downstream effector of PI3-K (Kandel and Hay, 1999),
was increased by anti–a6b4 antibodies in cells plated on
Ln-5. Together, these results strongly indicate that PI3-K
mediates a6b4-initiated inhibition of HaCaT haptotactic
migration on Ln-5.
In recent literature, PI3-K was reported to play a stimu-
latory role in growth factor–initiated cell migration (for re-
view, see Giancotti and Ruoslahti, 1999; Wells, 2000). How
can the same PI3-K enzyme, in the same cell system, medi-
ate both inhibition and stimulation of migration at the
same time? This apparent inconsistency may actually not
be difficult to account for, because of the complexity and
redundancies of the signaling pathways in which PI3-K
may be involved (Ren and Schwartz, 1998; Wymann and
Pirola, 1998; Rameh and Cantley, 1999; Vanhaesebroeck
and Waterfield, 1999; Nebl et al., 2000). Thus, there are
many hypothetical possibilities for envisioning PI3-K op-
erating in pathways that have distinct effects on HaCaT
migration. Distinct PI3-K isoforms may also be in play
(Zhang et al., 1998; Arcaro et al., 2000). Distinguishing
among these possibilities will have to await further charac-
terization of PI3-K signal transduction pathways.
We detected association of a6b4 with a class IA PI3-K
isoform. Activation of this isoform generally requires
translocation to the plasma membrane, mediated by the
adapter subunit (50, 55, or 85 kD) that links the p110 cata-
lytic subunit to a cell surface receptor with tyrosine kinase
domains (Wymann and Pirola, 1998). Integrin a6b4 has no
such kinase domain, but was shown to be physically associ-
ated with a receptor tyrosine kinase, erbB-2 or Her2/neu
(Falcioni et al., 1997), a member of the EGF receptor fam-
ily (Hynes and Stern, 1994; Alroy and Yarden, 1997).
Here, we demonstrate that binding to Ln-5 induces tyro-
sine phosphorylation of erbB-2 and that this effect is am-
plified by anti–a6b4 antibodies. Furthermore, we detected
increased association of p85 with this activated erbB-2.
Complexing of erbB-2 with p85 has been shown to lead to
increased p110 activity (Ram and Ethier, 1996; Olayioye
et al., 1998). These data corroborate the idea that erbB-2
may act as a signaling link between a6b4 and PI3-K.
Moreover, we also found that blockage of endogenous
erbB-2 by a specific inhibitor or by dominant-negative
erbB-2 abolished the inhibitory effect of anti–a6b4 anti-
bodies on a3b1-linked haptotaxis. These are independent
indications that a6b4 cooperates with erbB-2 to trigger
downstream signaling pathways regulating integrin-linked
functions.
Recent data on breast cancer cells revealed a stimula-
tory role for erbB-2 in migration (Spencer et al., 2000) that
may superficially seem in conflict with the negative role
we describe here. However, there are several critical dif-
ferences between the study by Spencer et al. (2000) and
ours, including the fact that cell migration was stimulated
by EGF-related peptides and was therefore chemotactic,
while we studied haptotaxis and the nature of the ECM
substrate. The difference in cell type may also be relevant.
It will be interesting, in future studies, to analyze possible
distinctive parameters of erbB-2 signaling in these differ-
ent migration systems.
Results with Fab fragments suggest that clustering of
a6b4 is not required for induction of the downstream sig-
naling we detected. On the other hand, addition of anti-
bodies appeared to amplify signals occurring when a6b4
engages with Ln-5, similar to amplification of FAK and
ERK1/2 phosphorylation by antibody TS2/16. The recep-
tor–ligand interactions between integrins and Ln-5 are not
well understood at the structural level, and it is therefore
difficult to interpret these antibody effects at this time.
Nonetheless, it is tempting to propose that antibodies may
modify binding of  a3b1 or  a6b4, respectively, to Ln-5,
thus shifting the balance of cellular responses to Ln-5.
Taken together, our data support a model whereby a
quiescent cell may be stably attached to Ln-5 via a3b1 and
a6b4. Upon selective activation of a3b1, the cell begins to
migrate haptotactically over Ln-5 until a6b4 engagement,
when stimulation of a PI3-K pathway may slow the cell
down. An important issue is, which molecules or struc-
tures are responsible for this shift in integrin dominance?
Ln-5 is such a candidate itself since it exists in several pro-
teolytically cleaved fragments that can either stimulate or
inhibit cell migration (Giannelli et al., 1997; Goldfinger et
al., 1998, 1999) and that might bind to a3b1 and a6b4 with
different affinities, thereby favoring adhesion or migra-
tion. A future challenge is to identify factors that, in vivo,
may produce the same effects as TS2/16 on haptotaxis.
In summary, our keratinocyte migration system pro-
vides a model for studying signaling pathways that control
haptotactic migration in cells that are a6b4 positive. These
include epithelial cells from the gastrointestinal tract, the
genitourinary tract, and breast gland. Furthermore, a6b4
is overexpressed or expressed de novo in many carcinoma
cell types. Further studies are necessary to clarify how
a6b4 signaling may relate to a3b1 functions when these
cell types come in contact with Ln-5 containing BM. A
crucial challenge is to identify signaling molecules down-
stream of the a6b4/erbB-2/PI3-K complex that are respon-
sible for interference with a3b1 dependent migration.
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